Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03065075 · ClinicalTrials.gov registry record · Phase 3
Effect of Phenazopyridine on Prolapse Surgery Voiding Trials
A Phase 3 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 3
- Development phase
- 152
- Enrollment target
NCT03065075 is a Phase 3 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 152 participants.
The verdict
NCT03065075, a Phase 3 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 152 participants
- Enrollment target
Study Summary
To determine if phenazopyridine reduces the rate of postoperative urinary retention after pelvic organ prolapse surgery.
Interventions
- DRUG Phenazopyridine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2019-02-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03065075
The ClinicalTrials.gov registry entry for NCT03065075 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phenazopyridine is the first listed.
NCT03065075 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03065075 about?
NCT03065075 is a clinical study titled "Effect of Phenazopyridine on Prolapse Surgery Voiding Trials". To determine if phenazopyridine reduces the rate of postoperative urinary retention after pelvic organ prolapse surgery.
What is the current status of trial NCT03065075?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 152 participants. The study started on 2017-02-01. Estimated completion is 2019-02-28.
What interventions are being tested in trial NCT03065075?
The interventions under investigation include: Phenazopyridine (DRUG).
Who is sponsoring clinical trial NCT03065075?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.